October 14, 2025 C-Path Q3 2025 Newsletter This year marks a historic milestone for C-Path as we celebrate 20 years of advancing regulatory science...
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub AMSTERDAM, October 16, 2025 — Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Diseas
October 14, 2025 Critical Path Institute to be Honored with Reagan-Udall Foundation Innovation Award Award honors regulatory science advances with measurable public health impact; ceremony December 9, 2025, Willard InterContinental
October 7, 2025 C-Path CEO Romero Featured in Scientific American Feature The piece explores the concept of healthspan — the years of life lived free from serious disease — a topic gaining momentum...
October 30, 2025 Rare/Orphan and Pediatric Disease Program Webinar: Addressing the Lack of Standardized Laboratory Reference Ranges in Neonatal Trials: Pilot GUI Launch C-Path's International Neonatal Consortium hosts the webinar, "Addressing the Lack of Standardized..."
September 30, 2025 C-Path Names Colin Hill to Board of Directors C-Path today announced the election of Colin Hill to its Board of Directors. Hill brings deep experience...
September 25, 2025 International Ataxia Awareness Day: Advancing Hope Through Collaboration and Innovation Every year on September 25, the global community comes together to recognize International Ataxia Awareness Day (IAAD).
September 22, 2025 C-Path’s Martinez Joins Help4HD Podcast in Special Guest Segment Critical Path Institute’s Executive Director of its Huntington’s Disease Regulatory Science Consortium (HD-RSC), joined...
September 18, 2025 The Critical Path Institute Podcast: Connecting the Dots in Pediatrics C-Path is excited to share the latest episode of our Connecting the Dots podcast. In this episode, C-Path CEO Klaus...
September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...